Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Doctors Can Now Prescribe Ozempic to Reduce Kidney Disease Risks in Diabetes Patients
Fact checked by Jillian Dara The Food and Drug Administration (FDA) on Tuesday approved Ozempic (semaglutide) to reduce the risk of complications and death in adults with both type 2 diabetes and chronic kidney disease.
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,
Ozempic Approval Expanded to Include T2D Patients With Chronic Kidney Disease
The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
Ozempic Receives New Indications in Chronic Kidney Disease
Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with chronic kidney disease.
Novo Nordisk expands Ozempic's turf with new FDA nod to curb kidney disease risks
When Novo Nordisk unveiled kidney outcomes data for its star GLP-1 medicine Ozempic last May, the company’s executive medical director suggested the results could help set a new standard for “holis | The FDA on Tuesday gave Ozempic a thumbs-up to reduce the risk of kidney disease worsening,
FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes
Doctors already use Ozempic to manage type 2 diabetes and reduce the risk of heart disease in patients with diabetes. This move, as reported by The Times, was based on research sh
Ozempic receives FDA nod for treating chronic kidney disease; experts explain how diabetes drug reduces CKD risk
The US Food and Drug Administration (FDA) approval is based on the clinical trials that showed how Ozempic, the diabetes drug, showed a reduced risk of kidney failure. Experts explain how the drug helps.
Weight-loss Drug Ozempic Can Benefit Patients With Kidney Diseases
In the US, 1 in 7 adults are experiencing some type of chronic kidney disease caused by diabetes. The new approval therefore allows doctor to prescribe Ozempic to lower the risk of kidney failure, dialysis and death from heart-related problems too.
FDA approves Ozempic to reduce risk of kidney disease progression, cardiovascular death
The Food and Drug Administration approved Ozempic to be used to lessen the risk of kidney disease from getting worse, end-stage kidney disease and cardiovascular disease-caused death for patients with type 2 diabetes and Dr.
8h
Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
1d
An Ozempic Expert Explains What You Need to Know Before Taking GLP-1 Drugs
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
Hosted on MSN
1d
Lighter but weaker? The hidden costs of Ozempic and weight-loss drugs for endurance athletes
Ozempic and other semaglutide medications have skyrocketed in popularity as weight-loss aids, with prescriptions surging by ...
2d
Heart Shrinkage Linked to Popular Weight-Loss Drug Ozempic/Semaglutide
Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...
13d
Meet ‘Super’ Ozempic: Higher Dose Semaglutide Leads to Even Greater Weight Loss In Major Trial
People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.
Newstalk
7h
Cork grandmother died after Ozempic caused organ failure
Breeda O’Donoghue told her GP she was having no problems with the medication as the dose was increased slightly over time.
6d
on MSN
Scientists find Ozempic may treat cancer, Alzheimer's and more. Is it hype or truly a "wonder drug?"
Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
1d
Ozempic May Reduce Bone Density; Know Other Possible Side Effects
A healthy diet with regular exercise can help with sustainable weight loss. However, the use of Ozempic may contribute to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Chronic kidney disease
Food and Drug Administration
Diabetes mellitus type 2
Feedback